Back
TG Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
TGTX
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
68
TGTX
TG Therapeutics
Last Price:
28.80
Seasonality Move:
21.95%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!TG Therapeutics Price Quote
$28.80
-0.01 (3.23%)
(Updated: November 9, 2024 at 5:49 AM ET)
TG Therapeutics Key Stats
Buy
68
TG Therapeutics (TGTX)
is a Buy
Day range:
$27.10 - $28.92
52-week range:
$9.81 - $28.92
Dividend yield:
0%
P/E ratio:
320.11
P/S ratio:
16.93
P/B ratio:
23.34%
Volume:
3.3M
Avg. volume:
2.9M
1-year change:
167.01%
Market cap:
$4.5B
Revenue:
$233.7M
EPS:
$-0.11
How Much Does TG Therapeutics Make?
-
How Much Are TG Therapeutics's Sales Annually?
TGTX Revenues are $233.7M -
How Much Profit Does TG Therapeutics's Make A Year?
TGTX net income is $12.7M
Is TG Therapeutics Growing As A Company?
-
What Is TG Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.49% -
What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.97%
TG Therapeutics Stock Price Performance
-
Did TG Therapeutics Stock Go Up Last Month?
TG Therapeutics share price went up by 31.91% last month -
Did TGTX's Share Price Rise Over The Last Year?
TGTX share price rose by 167.01% over the past 1 year
What Is TG Therapeutics 52-Week High & Low?
-
What Is TG Therapeutics’s 52-Week High Share Price?
TG Therapeutics has traded as high as $28.92 over the past 52 weeks -
What Is TG Therapeutics’s 52-Week Low Share Price?
TG Therapeutics has traded as low as $9.81 over the past 52 weeks
TG Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy TG Therapeutics?
-
How Much Debt Does TG Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does TG Therapeutics Have?
Cash and short term investments quarterly total is $341M -
What Is TG Therapeutics’s Book Value Per Share?
Book value per share is 1.23
Is TG Therapeutics Cash Flow Positive?
-
What Is TGTX Cash Flow From Operations?
Cash flow from operations (TTM) is $67.8M -
What Is TG Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $565K -
What Is TG Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$82.5M
TG Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TGTX return on invested capital is -5.71% -
What Is TG Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -3.55% -
What Is TGTX Return On Equity?
ROE is a measure of profitability and is -8.4%
TG Therapeutics Earnings Date & Stock Price
-
What Is TG Therapeutics's Stock Price Today?
A single share of TGTX can be purchased today for 28.81 -
What Is TG Therapeutics’s Stock Symbol?
TG Therapeutics trades on the nasdaq under the ticker symbol: TGTX -
When Is TG Therapeutics’s Next Earnings Date?
The next quarterly earnings date for TG Therapeutics is scheduled on February 28, 2025 -
When Is TGTX's next ex-dividend date?
TG Therapeutics's next ex-dividend date is November 10, 2024 -
How To Buy TG Therapeutics Stock?
You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
TG Therapeutics Competitors
-
Who Are TG Therapeutics's Competitors?
Below is a list of companies who compete with TG Therapeutics or are related in some way:
TG Therapeutics Dividend Yield
-
What Is TGTX Dividend Yield?
TG Therapeutics’s dividend yield currently is 0% -
What Is TG Therapeutics’s Payout Ratio?
TG Therapeutics’s payout ratio is 0% -
When Did TG Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 10, 2024 -
What Is TG Therapeutics’s Dividend Per Share?
TG Therapeutics pays a dividend of $0.00 per share
TG Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -97.26% | -40.92% |
Revenue: | -49.41% | 2.66% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 37.22 |
Upside from Last Price: | 29.2% |